We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.
3et3
From Proteopedia
(Difference between revisions)
m (Protected "3et3" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:3et3.png|left|200px]] | [[Image:3et3.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_3et3", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_3et3| PDB=3et3 | SCENE= }} | {{STRUCTURE_3et3| PDB=3et3 | SCENE= }} | ||
===Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid=== | ===Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_19116277}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 19116277 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_19116277}} | {{ABSTRACT_PUBMED_19116277}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
| - | *[[Peroxisome Proliferator-Activated Receptors]] | + | *[[PPAR-gamma|PPAR-gamma]] |
| + | *[[Peroxisome Proliferator-Activated Receptors|Peroxisome Proliferator-Activated Receptors]] | ||
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:019116277</ref><references group="xtra"/> |
[[Category: Histone acetyltransferase]] | [[Category: Histone acetyltransferase]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
| Line 33: | Line 23: | ||
[[Category: Acyltransferase]] | [[Category: Acyltransferase]] | ||
[[Category: Adiponectin]] | [[Category: Adiponectin]] | ||
| - | [[Category: Alternative splicing]] | ||
| - | [[Category: Chromosomal rearrangement]] | ||
[[Category: Diabetes]] | [[Category: Diabetes]] | ||
[[Category: Diabetes mellitus]] | [[Category: Diabetes mellitus]] | ||
| Line 46: | Line 34: | ||
[[Category: Obesity]] | [[Category: Obesity]] | ||
[[Category: Phosphoprotein]] | [[Category: Phosphoprotein]] | ||
| - | [[Category: Polymorphism]] | ||
[[Category: Ppar]] | [[Category: Ppar]] | ||
[[Category: Pparg]] | [[Category: Pparg]] | ||
| Line 56: | Line 43: | ||
[[Category: Transcription regulation]] | [[Category: Transcription regulation]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
| - | [[Category: Ubl conjugation]] | ||
| - | [[Category: Zinc]] | ||
[[Category: Zinc-finger]] | [[Category: Zinc-finger]] | ||
Revision as of 10:04, 26 July 2012
Contents |
Structure of PPARgamma with 3-[5-Methoxy-1-(4-methoxy-benzenesulfonyl)-1H-indol-3-yl]-propionic acid
Template:ABSTRACT PUBMED 19116277
About this Structure
3et3 is a 2 chain structure of Peroxisome Proliferator-Activated Receptors with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Artis DR, Lin JJ, Zhang C, Wang W, Mehra U, Perreault M, Erbe D, Krupka HI, England BP, Arnold J, Plotnikov AN, Marimuthu A, Nguyen H, Will S, Signaevsky M, Kral J, Cantwell J, Settachatgull C, Yan DS, Fong D, Oh A, Shi S, Womack P, Powell B, Habets G, West BL, Zhang KY, Milburn MV, Vlasuk GP, Hirth KP, Nolop K, Bollag G, Ibrahim PN, Tobin JF. Scaffold-based discovery of indeglitazar, a PPAR pan-active anti-diabetic agent. Proc Natl Acad Sci U S A. 2009 Jan 6;106(1):262-7. Epub 2008 Dec 30. PMID:19116277
Categories: Histone acetyltransferase | Homo sapiens | Wang, W. | Zhang, K Y.J. | Activator | Acyltransferase | Adiponectin | Diabetes | Diabetes mellitus | Disease mutation | Dna-binding | Drug discovery | Fragment-based drug discovery | Metabolic disease | Metal-binding | Nucleus | Obesity | Phosphoprotein | Ppar | Pparg | Ppargamma | Proto-oncogene | Receptor | Scaffold-based drug discovery | Transcription | Transcription regulation | Transferase | Zinc-finger
